Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells

被引:139
作者
Park, H
Kim, YH
Lim, YM
Han, I
Oh, ES [1 ]
机构
[1] Ewha Womans Univ, Ctr Cell Signaling Res, Seodaemoon Gu, Seoul 120750, South Korea
[2] Ewha Womans Univ, Dept Life Sci, Div Mol Life Sci, Seoul 120750, South Korea
[3] Ewha Womans Univ, Ewha Med Sch, Ewha Inst Neurosci, Seoul 120750, South Korea
关键词
D O I
10.1074/jbc.M202435200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Syndecan-2 is a transmembrane heparan sulfate proteoglycan whose function at the cell surface is unclear. In this study, we examined the function of syndecan-2 in colon cancer cell lines. In several colon cancer cell lines, syndecan-2 was highly expressed compared with normal cell lines. In contrast, syndecan-1 and -4 were decreased. Cell biological studies using the extracellular domain of recombinant syndecan-2 (2E) or spreading assay with syndecan-2 antibody-coated plates showed that syndecan-2 mediated adhesion and cytoskeletal organization of colon cancer cells. This interaction was critical for the proliferation of colon carcinoma cells. Blocking with 2E or antisense syndecan-2 cDNA induced G(0)/G(1) cell cycle arrest with concomitantly increased expression of p21, p27, and p53. Furthermore, blocking of syndecan-2 through antisense syndecan-2 cDNA significantly reduced tumorigenic activity in colon carcinoma cells. Therefore, increased syndecan-2 expression appears to be a critical for colon carcinoma cell behavior, and syndecan-2 regulates tumorigenic activity through regulation of adhesion and proliferation in colon carcinoma cells.
引用
收藏
页码:29730 / 29736
页数:7
相关论文
共 48 条
[1]  
AMRKKU M, 1994, J BIOL CHEM, V269, P27795
[2]   The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma [J].
Bayer-Garner, IB ;
Smoller, BR .
JOURNAL OF CUTANEOUS PATHOLOGY, 2001, 28 (02) :83-89
[3]   BIOLOGY OF THE SYNDECANS - A FAMILY OF TRANSMEMBRANE HEPARAN-SULFATE PROTEOGLYCANS [J].
BERNFIELD, M ;
KOKENYESI, R ;
KATO, M ;
HINKES, MT ;
SPRING, J ;
GALLO, RL ;
LOSE, EJ .
ANNUAL REVIEW OF CELL BIOLOGY, 1992, 8 :365-393
[4]   Extracellular matrix signaling: integration of form and function in normal and malignant cells [J].
Boudreau, N ;
Bissell, MJ .
CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (05) :640-646
[5]  
Carey DJ, 1997, BIOCHEM J, V327, P1
[6]   Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action [J].
Clasper, S ;
Vekemans, S ;
Fiore, M ;
Plebanski, M ;
Wordsworth, P ;
David, G ;
Jackson, DG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (34) :24113-24123
[7]   Fibronectin, integrins, and growth control [J].
Danen, EHJ ;
Yamada, KM .
JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 189 (01) :1-13
[8]   EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND SURVIVAL IN UPPER AERODIGESTIVE TRACT CANCER [J].
DASSONVILLE, O ;
FORMENTO, JL ;
FRANCOUAL, M ;
RAMAIOLI, A ;
SANTINI, J ;
SCHNEIDER, M ;
DEMARD, F ;
MILANO, G .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) :1873-1878
[9]   Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence [J].
Day, RM ;
Hao, XP ;
Ilyas, M ;
Daszak, P ;
Talbot, IC ;
Forbes, A .
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1999, 434 (02) :121-125
[10]   Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma [J].
Dhodapkar, MV ;
Kelly, T ;
Theus, A ;
Athota, AB ;
Barlogie, B ;
Sanderson, RD .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) :368-371